Intravenous liposomal prednisolone downregulates in situ TNF-α production by T-cells in experimental autoimmune encephalomyelitis

Journal of Histochemistry and Cytochemistry

Volumn 51, Issue 9, 2003, Pages 1241-1244

  Schmidt, Jens ^a,c   Metselaar, Josbert M ^b   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Autoimmunity; Drug targeting; EAE; Glucocorticosteroids; Immunohistochemical double; Labeling; Long circulating liposomes; Multiple sclerosis; Neuroinflammation

Indexed keywords

GLUCOCORTICOID; LIPOSOME; MACROGOL; PREDNISOLONE; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG TARGETING; FEMALE; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALIA;

EID: 0041319085     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540305100915     Document Type: Article

References (12)

1. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neurosci 4:1116-1122
2. Brusaferri F, Candelise L (2000) Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 247:435-442
3. Gold R, Buttgereit F, Toyka KV (2001) Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117:1-8
4. Kassiotis G, Kollias G (2001) Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 193:427-434
5. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, et al. (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83
6. Metselaar JM, Wauben MHM, Wagenaar-Hilbers JPA, Boerman OC, Storm G (in press) Joint targeting of glucocorticoids with long-circulating liposomes induces complete remission of experimental arthritis. Arthritis Rheum
7. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
8. Oliveri RL, Valentino P, Russo C, Sibilia G, Aguglia U, Bono F, Fera F, et al. (1998) Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. Neurology 50:1833-1836
9. Schmidt J, Gold R, Schonrock L, Zettl UK, Hartung HP, Toyka KV (2000) T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123:1431-1441
10. Schmidt J, Metselaar JM, Wauben MHM, Toyka KV, Storm G, Gold R (in press) Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain
11. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR (2002) Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci 25:491-505
12. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457-465